Snapshot date: 2026-10-18 · Built: 2026-10-19T15:41:39+00:00 · Publication status: REVIEW

COMPANY RESEARCH

GE HealthCare Technologies Inc.

GEHC · United States · Healthcare

INSIDER SIGNAL

Insider activity score：81.0 / 100

8 insiders · 8 purchase events · $6.42m net purchases

US #51 · United States #51

WHY THIS SIGNAL?

Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+35.0 / 35

How many distinct insiders bought in the cluster

Purchase size+22.2 / 25

Purchase value relative to company size and liquidity

Role+7.0 / 20

The seniority and relevance of participating insiders

Recency+0.8 / 10

How recently the purchases occurred

Conviction+10.0 / 10

How clearly buying stands out from other activity

What is holding the score back?

⚠ Insider role contributes less on the current role scale
⚠ Purchase activity is becoming less recent
✓ Broad buyer cluster · 4+ distinct filers

The role contribution follows the US model's seniority ladder.

BUYING PROFILE

8 events · 8 insiders · 180d

Cluster 100%Repeat 0%Independent 0%Large 0%

Percentages are mutually exclusive and sum to 100%.

Buying concentration

78%

Largest buyer：CULP H LAWRENCE JR · 5.00m USD
Gross qualified purchase transaction-line value：6.42m USD

The headline $ total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.

This is a ranking under the current US screening rules—not a probability of gain, return forecast, or buy recommendation.

Key purchase quotes (filing currency)

Filer	Price per unit	Trade date
Lobo Kevin	64.18 USD	May 22, 2026
Hochman Rodney F	62.03 USD	May 12, 2026
CULP H LAWRENCE JR	61.88 USD	May 6, 2026

Model details

Cluster breakdown (does not change the score)

15-day buyer breadth (count): 7 distinct reported filers
Peak time window: 2026-04-30 to 2026-05-12
Current breadth input: 1.000 (capped at 4+ buyers)
Buyer independence: Not yet measured; related-party fields are not cross-market comparable

What the filings show

🟢 Recent eligible purchase
Lobo Kevin · 642k USD · Price 64.18 USD · May 22, 2026
🟢 PDMR purchase
Hochman Rodney F · 100k USD · Price 62.03 USD · May 12, 2026
🟢 PDMR purchase
CULP H LAWRENCE JR · 5.00m USD · Price 61.88 USD · May 6, 2026
🟡 5 remaining qualified transaction line(s) across 5 disclosure(s)
🔴 34 other transaction line(s) are not counted as discretionary-buying evidence; 13 have zero price

Insider vs stock price

6 purchase day(s), 8 purchase line(s) in the 180-day window.

Daily close (USD)Day with an insider purchaseTwo or more insiders the same day

Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.

If you had followed the purchase

Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.

Amount put in (USD)

Made public	Insiders	In this stock, now	In the median peer stock, now	Difference
2026-04-30	2	1,081 +8.1%	900 −10.0%	+180 +18.0 pts
2026-05-01	1	1,077 +7.7%	897 −10.3%	+180 +18.0 pts
2026-05-07	2	1,072 +7.2%	906 −9.4%	+166 +16.6 pts
2026-05-11	1	1,065 +6.5%	918 −8.2%	+147 +14.7 pts
2026-05-13	1	1,062 +6.2%	926 −7.4%	+136 +13.6 pts
2026-05-26	1	1,024 +2.4%	917 −8.3%	+107 +10.7 pts

6 of 6 disclosure day(s) ended ahead of the median peer stock.

Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (1049 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.

Insider timeline

7 insiders bought within 13 days, 30 Apr to 12 May: 4 Board member, 1 CEO / chair, 1 Role not classified, 1 CFO. 1 more bought afterwards. The share closed at 60.84 on the first of those days and at 65.74 most recently (+8.1%). That week 96 companies across United States disclosed insider purchases, an ordinary week (18 of the last 26).

Tap an item for what it means.

●A purchase: the bigger the dot, the more was bought

Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.

▮Purple band: several insiders bought within 15 days

The band marks the stretch with the most different buyers: at most 15 days long and at least two people. Here it is 30 Apr – 12 May, with 7 insiders. Only the strongest stretch is marked. Several people deciding the same thing is harder to explain by one person's private reasons, but insiders often buy together just after a closed period ends, so compare it with the grey weekly bars.

Blue line: this share's price, −9.0% over these six months

The closing price of each day, from 72.26 on 2026-04-21 to 65.74 on 2026-10-09. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.

Dashed line: the typical stock on the same exchange, −11.1%

Taken from the 1230 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −9.0%, the typical one −11.1%, 2.1 points ahead. It is not an index and not a comparison within one industry.

▂Grey bars: companies across United States disclosing purchases each week

A taller bar is a week in which more companies disclosed insider purchases. The purple bar is the week of the band above: 96 companies, number 18 of the last 26 weeks. If that week was a peak anyway, buying together is less special than it looks.

This company: insiders buying per month, last 12 months

Nov

Dec

Jan

Feb

Mar

2Apr

6May

Jun

Jul

Aug

Sep

Oct

Darker bars are inside the 180-day window above.

Who traded

Insider	Role	Purchases	Sales	Bought	First purchase	Share price since
Arduini Peter J	CEO / chair	1	—	249.8k USD	2026-04-30	+8.1%
SACCARO JAMES	CFO	1	—	200.6k USD	2026-05-01	+7.7%
CULP H LAWRENCE JR	Board member	1	—	5.0M USD	2026-05-06	+6.5%
Stromberg William J	Board member	1	—	61.7k USD	2026-05-06	+6.5%
Yang Watkin Phoebe L.	Board member	1	—	63.0k USD	2026-05-08	+3.6%
Hochman Rodney F	Board member	1	—	100.4k USD	2026-05-12	+5.5%
Lobo Kevin	Board member	1	—	641.8k USD	2026-05-22	+2.4%
Jimenez Frank R	Role not classified	1	—	105.8k USD	2026-04-30	+8.1%

Why this score? · Model details

Priority = 100 × Σ(fixed weight × 0–1 rule-based input)

Factor	Weight	This company input	Point contribution
15-day buyer breadth (count)	35%	1.000	35.0
Qualified-buy size	25%	0.887	22.2
Role informativeness (inverted)	20%	0.650	13.0
Recency	10%	0.083	0.8
Buy/sell conviction	10%	1.000	10.0

This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.

BULL VS BEAR

Two readings of this buying

The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.

Where the evidence comes from

Independent evidence does not object: the purchases themselves carry bull lines (several insiders together, more buyers than usual here, large purchases, purchase added much to the holding); share price and trading, short sellers were checked and none crosses a bear threshold. No data is held for: company results, company actions.

The insider purchases themselvesBullseveral insiders together, more buyers than usual here, large purchases, purchase added much to the holding Bearlatest purchase is old4 checked, under the threshold · 1 missing
Share price and trading2 checked, under the threshold
Short sellers2 checked, under the threshold
Company results2 missing
Company actionsno data held

Bull case · the buying is informative

7 insiders bought within 15 days (2026-04-30 to 2026-05-12). Several people reaching the same decision at the same time is hard to put down to one person's circumstances.
No insider bought in the 180 days before this window; 8 have bought in it. The buying is new for this company, not a habit.
Insiders committed a net $6.4M of their own money in 180 days.
8 of 8 purchase filings state the shares held before and after. The largest addition to an existing holding took it from 4,363 to 14,363 shares (+229%). A holding here is one way of owning the shares: directly, or through one named trust or entity.

Bear case · discount it

The latest purchase was 149 days ago (2026-05-22). A reporting period has passed since, so what the buyers knew then may already be public.

Evidence still missing

No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
The company's market value is not captured, so the purchases cannot be stated as a share of the business or of its trading volume.
No earnings, margin or cash-flow figures are captured for this company. The latest annual and interim reports are where to check whether the business is improving or deteriorating.

Checked and under the threshold: 8, 1 close to it

BearThe largest buyer accounts for 78% of the value bought. Counted for the bear side from 80%. close to the threshold
BearNo insider sale is recorded in the same 180 days.
BearThe share price changed −10% over six months (three months +0.66%, one month +2.3%) and stands 27% below its 52-week high. Counted for the bear side from a fall of 20%.
BearOver three months the share price changed +0.66% and the median of 219 Healthcare companies changed −12%: ahead by 13 points. Counted for the bear side from 20 points behind.
BearNone of the 8 purchase filings ticks Form 4's 10b5-1 box.
BearOver the last 5 trading days to 2026-10-16, 65% of this stock's off-exchange volume was sold short; over the 60 days before, 60%. The market's median is 50%. This is trading volume, not a position: a market maker who sells short and covers the same day is counted, so about half of all volume is short on an ordinary day. It is shown for comparison and counts for neither side.
BearNo insider filing in the last 180 days opened a hedge on this stock.
BearFINRA short interest on 2026-09-30 equals 4.7 days of average trading volume and 4.1% of the 451,686,252 shares outstanding, up 9.5% from the previous report. Counted for the bear side from 10 days, or from 10% of the shares outstanding.

Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.

Signal history

81.0 / 100

Latest recorded score

↓ -7.0 ptssince the first recorded snapshot on 2026-10-09; 9 calendar days observed

Recorded snapshots: 7
First snapshot: 2026-10-09

There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.

Why did it change?

Less than 30 days of comparable history is available, so factor movement is not yet decomposed.

Signal score history

Fixed 0–100 scale; dates are spaced by calendar time.

Recent recorded points

Oct 9, 202688.0
Oct 13, 202681.2
Oct 14, 202681.2
Oct 15, 202681.1
Oct 18, 202681.0

View all recorded scores

Snapshot date	Signal score
2026-10-09	88.0
2026-10-12	81.2
2026-10-13	81.2
2026-10-14	81.2
2026-10-15	81.1
2026-10-16	81.1
2026-10-18	81.0

Sector context

Healthcare

Buying breadth: 4.1% (42 / 1,029 issuers)
Sector rank: #8 / 13

This is sector-level research context. It does not affect the Insider Signal or ranking.

View US sector research →

Insider profile outcomes

Historical performance following insider filings. The company role is translated below each name while preserving the original title.

Excess return = stock return − S&P 500 ETF (SPY adjusted close) return over the same period.
Hit rate = completed events with positive excess return ÷ total completed events.
Price coverage = valid point-in-time prices ÷ events mature enough for that period.
Returns start on the first shared trading session on or after publication.
Small-sample rule: n<5 is shown for transparency and is not scored.

Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.

Jimenez Frank RDirector | GC & Corporate Secretary1 completed 20D event(s)

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	50.0% (1/2)	0.0% (0/1)	-1.0%	-1.0%	-1.0%
20D	1Small sample	50.0% (1/2)	0.0% (0/1)	-2.8%	-2.8%	-2.8%
60D	1Small sample	50.0% (1/2)	100.0% (1/1)	+2.1%	+2.1%	+2.1%
120D	0No data	0.0% (0/1)	—	—	—	—

First purchase in 12M

1/1

Large purchase ≥ $100k

2/2

Cluster buying · 15D

1/2

Buying the dip · ≥20% below prior 52W high

1/1

Routine / opportunistic

Not classifiable

Arduini Peter JPresident and CEO1 completed 20D event(s)

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	100.0% (1/1)	0.0% (0/1)	-1.0%	-1.0%	-1.0%
20D	1Small sample	100.0% (1/1)	0.0% (0/1)	-2.8%	-2.8%	-2.8%
60D	1Small sample	100.0% (1/1)	100.0% (1/1)	+2.1%	+2.1%	+2.1%
120D	0No data	Awaiting maturity	—	—	—	—

First purchase in 12M

1/1

Large purchase ≥ $100k

1/1

Cluster buying · 15D

1/1

Buying the dip · ≥20% below prior 52W high

1/1

Routine / opportunistic

Not classifiable

CULP H LAWRENCE JRDirector1 completed 20D event(s)

Period	Completed events	Price coverage	Hit rate	Median excess return	Average excess return	Worst excess return
5D	1Small sample	100.0% (1/1)	0.0% (0/1)	-0.1%	-0.1%	-0.1%
20D	1Small sample	100.0% (1/1)	100.0% (1/1)	+4.6%	+4.6%	+4.6%
60D	1Small sample	100.0% (1/1)	100.0% (1/1)	+8.9%	+8.9%	+8.9%
120D	0No data	Awaiting maturity	—	—	—	—

First purchase in 12M

1/1

Large purchase ≥ $100k

1/1

Cluster buying · 15D

1/1

Buying the dip · ≥20% below prior 52W high

1/1

Routine / opportunistic

Not classifiable

Signal outcomes

Calculated from immutable US ranking snapshots; excess return is stock return minus SPY return. Newly saved snapshots remain pending until each forward horizon matures. This never affects the US score.

Horizon	Status	Result
5D	Awaiting maturity	—
20D	Awaiting maturity	—
60D	Awaiting maturity	—
120D	Awaiting maturity	—

Market context

PRICE PERFORMANCE

+2.3%

+0.7%

-10.2%

12M

-12.5%

VOLATILITY & LIQUIDITY

Volatility: 35.0%
Beta: —
Avg daily volume: $270.3M

VALUATION

Market cap: —
P/E: —

FUNDAMENTALS

Profit margin: —
ROE: —
Industry: —

Prices to 11 Oct 2026: OpenBB/yfinance; volume from price cache (yfinance). It does not affect the insider score or rank.

Insiders' buying price vs the latest close

The latest close in the price history is more than a week old.

Buying size vs market trading

Complete price and volume history is not yet available.

Market-data coverage: 0 verified sessions · Latest session: — · Ratio status: Unavailable

Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.

Regulatory filings

Insider filing announcement · published 2026-09-16 · trade date 2026-09-14
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03

Unfold all 59 filings

Insider filing announcement · published 2026-09-16 · trade date 2026-09-14
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-04 · trade date 2026-09-03
Insider filing announcement · published 2026-09-03 · trade date 2026-09-01
Insider filing announcement · published 2026-09-03 · trade date 2026-09-01
Insider filing announcement · published 2026-09-03 · trade date 2026-09-01
Insider filing announcement · published 2026-09-03 · trade date 2026-09-01
Insider filing announcement · published 2026-09-03 · trade date 2026-09-01
Insider filing announcement · published 2026-09-03 · trade date 2026-09-01
Insider filing announcement · published 2026-08-18 · trade date 2026-08-15
Insider filing announcement · published 2026-05-26 · trade date 2026-05-22
Insider filing announcement · published 2026-05-19 · trade date 2026-05-15
Insider filing announcement · published 2026-05-19 · trade date 2026-05-15
Insider filing announcement · published 2026-05-13 · trade date 2026-05-12
Insider filing announcement · published 2026-05-11 · trade date 2026-05-08
Insider filing announcement · published 2026-05-11 · trade date 2026-05-07
Insider filing announcement · published 2026-05-11 · trade date 2026-05-07
Insider filing announcement · published 2026-05-11 · trade date 2026-05-07
Insider filing announcement · published 2026-05-11 · trade date 2026-05-07
Insider filing announcement · published 2026-05-11 · trade date 2026-05-07
Insider filing announcement · published 2026-05-11 · trade date 2026-05-07
Insider filing announcement · published 2026-05-07 · trade date 2026-05-06
Insider filing announcement · published 2026-05-07 · trade date 2026-05-06
Insider filing announcement · published 2026-05-01 · trade date 2026-05-01
Insider filing announcement · published 2026-04-30 · trade date 2026-04-30
Insider filing announcement · published 2026-04-30 · trade date 2026-04-30
Insider filing announcement · published 2026-03-17 · trade date 2026-03-13
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-03-04 · trade date 2026-03-02
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-17 · trade date 2026-02-12
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01
Insider filing announcement · published 2026-02-03 · trade date 2026-02-01

Results and insider purchases

Results (8-K)	Bought within 5 sessions	Bought within 20 sessions
2026-07-2906:25 ET · before the open	None	None
2026-07-2316:17 ET · after the closeFirst session 2026-07-24	None	None
2026-04-2906:25 ET · before the open	3 · $556.2KArduini Peter J; SACCARO JAMES; Jimenez Frank R	8 · $6.4MCULP H LAWRENCE JR; Lobo Kevin; Arduini Peter J
2026-02-0406:25 ET · before the open	None	None

Results dates are the company's 8-K filings to the SEC under Item 2.02 (results of operations); one filed after the close counts from the next session. Purchases are open-market buys reported on Form 4 (code P), by trade date; a Form 4 can arrive two business days after the trade, so the latest days can still fill in. Facts only; this does not change the score or rank.

Ownership and trading-plan context

Direct / indirect ownership	Unavailable
10b5-1 filing evidence	Unavailable
Evidence retrieved	Unavailable

These are accession-level filing fields. Unavailable means the evidence was not fetched or parsed; it is never inferred as “No” and does not adjust the US score.

Filing evidence

These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.

Excluded transactions & classification

8 qualifying purchase disclosure(s) · 8 transaction line(s)

May 22, 2026Open market purchase

Lobo Kevin · Director

Common Stock, par value $0.01 per share · 10000.0 shares × 64.18 USD · 641800.0000000001 USD

Open filing

May 12, 2026Open market purchase

Hochman Rodney F · Director

Common Stock, par value $0.01 per share · 1618.0 shares × 62.03 USD · 100364.54000000001 USD

Open filing

May 8, 2026Open market purchase

Yang Watkin Phoebe L. · Director

Common Stock, par value $0.01 per share · 1000.0 shares × 63.01 USD · 63010.0 USD

Open filing

Unfold all 5 remaining filing row(s)

Transaction date	Published	Filer	Role	Transaction	Instrument	Price (local currency)	Quote currency	Volume	Reported value (local currency)	Source
2026-05-06	2026-05-07	CULP H LAWRENCE JR	Director	Open market purchase	Common Stock, par value $0.01 per share	61.88 USD	USD	80805.0	5000213.4 USD	Open filing
2026-05-06	2026-05-07	Stromberg William J	Director	Open market purchase	Common Stock, par value $0.01 per share	61.69 USD	USD	1000.0	61690.0 USD	Open filing
2026-05-01	2026-05-01	SACCARO JAMES	Chief Financial Officer	Open market purchase	Common Stock, par value $0.01 per share	60.6 USD	USD	3310.0	200586.0 USD	Open filing
2026-04-30	2026-04-30	Jimenez Frank R	GC & Corporate Secretary	Open market purchase	Common Stock, par value $0.01 per share	60.45 USD	USD	1750.0	105787.5 USD	Open filing
2026-04-30	2026-04-30	Arduini Peter J	President and CEO	Open market purchase	Common Stock, par value $0.01 per share	59.93 USD	USD	4169.0	249848.17 USD	Open filing

Showing 8 of 8 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level $ aggregate is separately FX-normalised for research ranking, not a trade-date conversion.

Other disclosed transactions · excluded from score

View 69 other transaction(s)

Mar 13, 2026Grant or award

Lobo Kevin · Director

Common Stock, par value $0.01 per share · 777.0 shares × 0.0 USD · 0.0 USD

Open filing

Mar 2, 2026Grant or award

Bankes Jeannette · CEO, Patient Care Solutions

Common Stock, par value $0.01 per share · 6861.0 shares × 0.0 USD · 0.0 USD

Open filing

Mar 2, 2026Grant or award

Jimenez Frank R · GC & Corporate Secretary

Common Stock, par value $0.01 per share · 10915.0 shares × 0.0 USD · 0.0 USD

Open filing

Unfold all 66 remaining filing row(s)

Transaction date	Published	Filer	Role	Transaction	Instrument	Price (local currency)	Quote currency	Volume	Reported value (local currency)	Source
2026-03-02	2026-03-04	Kass-Hout Taha	Chief Technology Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	13254.0	0.0 USD	Open filing
2026-03-02	2026-03-04	Holton Adam Y	Chief People Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	5457.0	0.0 USD	Open filing
2026-03-02	2026-03-04	Newcomb George A.	Chief Accounting Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	1309.0	0.0 USD	Open filing
2026-03-02	2026-03-04	O'Neill Kevin Michael	CEO, PDx	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	6549.0	0.0 USD	Open filing
2026-03-02	2026-03-04	Rackliffe Philip	CEO, AVS	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	9356.0	0.0 USD	Open filing
2026-03-02	2026-03-04	Rott Roland	CEO, Imaging	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	8576.0	0.0 USD	Open filing
2026-03-02	2026-03-04	SACCARO JAMES	Chief Financial Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	12475.0	0.0 USD	Open filing
2026-03-02	2026-03-04	Arduini Peter J	President and CEO	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	49120.0	0.0 USD	Open filing
2026-02-12	2026-02-17	Newcomb George A.	Chief Accounting Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	802.0	63518.4 USD	Open filing
2026-02-12	2026-02-17	Newcomb George A.	Chief Accounting Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	2523.0	0.0 USD	Open filing
2026-02-12	2026-02-17	O'Neill Kevin Michael	CEO, PDx	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	6938.0	0.0 USD	Open filing
2026-02-12	2026-02-17	O'Neill Kevin Michael	CEO, PDx	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	3261.0	258271.2 USD	Open filing
2026-02-12	2026-02-17	Rackliffe Philip	CEO, AVS	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3154.0	0.0 USD	Open filing
2026-02-12	2026-02-17	Rackliffe Philip	CEO, AVS	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	1174.0	92980.8 USD	Open filing
2026-02-12	2026-02-17	Rott Roland	CEO, Imaging	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	3943.0	312285.60000000003 USD	Open filing
2026-02-12	2026-02-17	Rott Roland	CEO, Imaging	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	7885.0	0.0 USD	Open filing
2026-02-12	2026-02-17	Kass-Hout Taha	Chief Technology Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	7787.0	616730.4 USD	Open filing
2026-02-12	2026-02-17	Kass-Hout Taha	Chief Technology Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	23339.0	0.0 USD	Open filing
2026-02-12	2026-02-17	Jimenez Frank R	GC & Corporate Secretary	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	22078.0	0.0 USD	Open filing
2026-02-12	2026-02-17	Jimenez Frank R	GC & Corporate Secretary	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	8357.0	661874.4 USD	Open filing
2026-02-12	2026-02-17	SACCARO JAMES	Chief Financial Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	8570.0	678744.0 USD	Open filing
2026-02-12	2026-02-17	SACCARO JAMES	Chief Financial Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	22610.0	0.0 USD	Open filing
2026-02-12	2026-02-17	Arduini Peter J	President and CEO	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	79.2 USD	USD	33445.0	2648844.0 USD	Open filing
2026-02-12	2026-02-17	Arduini Peter J	President and CEO	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	74908.0	0.0 USD	Open filing
2026-02-01	2026-02-03	O'Neill Kevin Michael	CEO, PDx	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	462.0	36484.14 USD	Open filing
2026-02-01	2026-02-03	Rackliffe Philip	CEO, AVS	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	189.0	14925.33 USD	Open filing
2026-02-01	2026-02-03	Kass-Hout Taha	Chief Technology Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	847.0	66887.59 USD	Open filing
2026-02-01	2026-02-03	Newcomb George A.	Chief Accounting Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	108.0	8528.76 USD	Open filing
2026-02-01	2026-02-03	Rott Roland	CEO, Imaging	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	558.0	44065.26 USD	Open filing
2026-02-01	2026-02-03	Jimenez Frank R	GC & Corporate Secretary	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	947.0	74784.59 USD	Open filing
2026-02-01	2026-02-03	SACCARO JAMES	Chief Financial Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	948.0	74863.56 USD	Open filing
2026-02-01	2026-02-03	Arduini Peter J	President and CEO	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	78.97 USD	USD	3210.0	253493.69999999998 USD	Open filing
2026-05-15	2026-05-19	Rackliffe Philip	CEO, AIS	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	16458.0	0.0 USD	Open filing
2026-05-15	2026-05-19	Bankes Jeannette	CEO, Patient Care Solutions	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	62.67 USD	USD	5535.0	346878.45 USD	Open filing
2026-05-07	2026-05-11	Yang Watkin Phoebe L.	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-05-07	2026-05-11	CULP H LAWRENCE JR	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-05-07	2026-05-11	CULP H LAWRENCE JR	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	4157.0	0.0 USD	Open filing
2026-05-07	2026-05-11	Hochman Rodney F	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-05-07	2026-05-11	Hochman Rodney F	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	2689.0	0.0 USD	Open filing
2026-05-07	2026-05-11	LESJAK CATHERINE A	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-05-07	2026-05-11	Lobo Kevin	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-05-07	2026-05-11	Madden Anne T	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-05-07	2026-05-11	Madden Anne T	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	2282.0	0.0 USD	Open filing
2026-05-07	2026-05-11	Stromberg William J	Director	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	3586.0	0.0 USD	Open filing
2026-09-14	2026-09-16	Grogan William K	Chief Financial Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	62256.0	0.0 USD	Open filing
2026-09-14	2026-09-16	Grogan William K	Chief Financial Officer	Grant or award	Common Stock, par value $0.01 per share	0.0 USD	USD	12840.0	0.0 USD	Open filing
2026-09-03	2026-09-04	Rackliffe Philip	CEO, AIS	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	798.0	56306.880000000005 USD	Open filing
2026-09-03	2026-09-04	O'Neill Kevin Michael	CEO, PDx	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	718.0	50662.08 USD	Open filing
2026-09-03	2026-09-04	Newcomb George A.	Chief Accounting Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	112.0	7902.72 USD	Open filing
2026-09-03	2026-09-04	Kass-Hout Taha	Chief Technology Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	1502.0	105981.12000000001 USD	Open filing
2026-09-03	2026-09-04	Jimenez Frank R	GC & Corporate Secretary	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	1480.0	104428.8 USD	Open filing
2026-09-03	2026-09-04	Holton Adam Y	Chief People Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	673.0	47486.880000000005 USD	Open filing
2026-09-03	2026-09-04	Estrampes Catherine	Chief Commer. & Growth Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	508.0	35844.48 USD	Open filing
2026-09-03	2026-09-04	Arduini Peter J	President and CEO	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	70.56 USD	USD	6303.0	444739.68 USD	Open filing
2026-09-01	2026-09-03	Rackliffe Philip	CEO, AIS	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	226.0	16097.980000000001 USD	Open filing
2026-09-01	2026-09-03	Rackliffe Philip	CEO, AIS	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	340.0	24218.2 USD	Open filing
2026-09-01	2026-09-03	Rackliffe Philip	CEO, AIS	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	290.0	20656.7 USD	Open filing
2026-09-01	2026-09-03	Kass-Hout Taha	Chief Technology Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	1296.0	92314.08 USD	Open filing
2026-09-01	2026-09-03	Kass-Hout Taha	Chief Technology Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	1644.0	117102.12000000001 USD	Open filing
2026-09-01	2026-09-03	Jimenez Frank R	GC & Corporate Secretary	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	1380.0	98297.40000000001 USD	Open filing
2026-09-01	2026-09-03	Jimenez Frank R	GC & Corporate Secretary	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	1751.0	124723.73000000001 USD	Open filing
2026-09-01	2026-09-03	Holton Adam Y	Chief People Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	659.0	46940.57 USD	Open filing
2026-09-01	2026-09-03	Bankes Jeannette	CEO, Patient Care Solutions	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	1064.0	75788.72 USD	Open filing
2026-09-01	2026-09-03	Arduini Peter J	President and CEO	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	6043.0	430442.89 USD	Open filing
2026-09-01	2026-09-03	Arduini Peter J	President and CEO	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	71.23 USD	USD	5472.0	389770.56 USD	Open filing
2026-08-15	2026-08-18	Holton Adam Y	Chief People Officer	Shares withheld for tax or exercise price	Common Stock, par value $0.01 per share	73.69 USD	USD	1360.0	100218.4 USD	Open filing

Showing 69 of 69 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level $ aggregate is separately FX-normalised for research ranking, not a trade-date conversion.

Snapshot & identity

Snapshot date: 2026-10-18
Ticker: GEHC
ISIN: —
Sector: Healthcare
Industry: —

Company logos by Parqet

How to read Form 4 transaction codes

Code	Interpretation	Screen treatment
P	Open-market / private purchase	Buy evidence when the security is qualifying equity
S	Sale	Sell evidence when the security is qualifying equity
A	Grant / award	Context only
F	Tax-related withholding	Context only
M	Option exercise	Context only
G	Gift	Context only
J / L	Other / non-directional	Context only

P/S rows for options, warrants, compensation units and debt remain visible for audit but are excluded from equity scores and quotes.

GE HealthCare Technologies Inc.

WHY THIS SIGNAL?

Score anatomy

What is holding the score back?

BUYING PROFILE

Buying concentration

Key purchase quotes (filing currency)

Cluster breakdown (does not change the score)

What the filings show

Insider vs stock price

If you had followed the purchase

Insider timeline

This company: insiders buying per month, last 12 months

Who traded

Two readings of this buying

Where the evidence comes from

Bull case · the buying is informative

Bear case · discount it

Evidence still missing

Signal score history

Recent recorded points

Sector context

Insider profile outcomes

Signal outcomes

Market context

PRICE PERFORMANCE

VOLATILITY & LIQUIDITY

VALUATION

FUNDAMENTALS

Insiders' buying price vs the latest close

Buying size vs market trading

Regulatory filings

Results and insider purchases

Ownership and trading-plan context

Filing evidence

Other disclosed transactions · excluded from score

Snapshot & identity

Share this page

How to read Form 4 transaction codes